Researchers identify an unexpected driver of cancer immunotherapy resistance
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has identified an unexpected driver of cancer immunotherapy resistance: the harmful effect of chronic Type I Interferon signaling on tumor-killing CD8+ T cells. These findings provided new insights into the development of exhausted CD8+ T cells, which no longer effectively … Read more